Prostate-specific Antigen (PSA) Screening in Asymptomatic Men

Prostate cancer screening in asymptomatic men remains an area of significant controversy, with the potential benefits and harms continuing to be debated among health professionals and the public after more than a decade of use.

This report reviews the current evidence regarding the effectiveness of screening for prostate cancer in asymptomatic men, using a blood test called prostate-specific antigen (PSA).